Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

The case for screening is even more urgent in India. According to GLOBOCAN estimates from 2022, India recorded roughly 1.4 million new cancer cases and over 910,000 deaths due to cancer. Notably, the ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

The FDA approved the first at-home test for cervical cancer screening, developed by Teal Health. In clinical trials, the accuracy of self-testing with Teal's wand matched that of a cancer screening ...